stockportfolio.pro
ALGN vs EXEL: Which Stock Is the Better Buy?
Align Technology, Inc. and Exelixis, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — ALGN vs EXEL, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Align Technology, Inc. (ALGN) | Exelixis, Inc. (EXEL) | |
|---|---|---|
| Market cap | $13.2B | $13.4B |
| Revenue (latest FY) | $4.03B | $2.32B |
| Net income (latest FY) | $410.35M | $782.57M |
| Revenue growth (5y CAGR) | 10.3% | 18.6% |
| Net margin | 10.2% | 33.7% |
| Return on equity | 10.1% | 36.2% |
| P/E ratio | 31.1 | 17.6 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 10 | 9 |
| Positive free cash flow | Yes | Yes |
See the full ALGN vs EXEL breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open ALGN's full financials → Open EXEL's full financials →More comparisons
Frequently asked questions
Which is bigger, ALGN or EXEL?
Exelixis, Inc. is larger by market capitalization — $13.4B versus $13.2B.
Which grows faster, ALGN or EXEL?
Over the last five fiscal years, Exelixis, Inc. grew revenue faster — 18.6%/yr versus 10.3%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.